tiprankstipranks
Madrigal Pharmaceuticals Inc (MDGL)
NASDAQ:MDGL
Holding MDGL?
Track your performance easily

Madrigal Pharmaceuticals (MDGL) Financial Statements

1,134 Followers

Madrigal Pharmaceuticals Financial Overview

Madrigal Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-25.073; its P/E ratio is -12.30; Madrigal Pharmaceuticals is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $-4.51. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 62.17M$ 14.64M---
Gross Profit$ 62.17M$ 14.64M---
EBIT$ -103.28M$ -148.31M$ -143.70M-$ -95.24M
EBITDA$ -102.51M$ -147.58M$ -142.88M-$ -94.43M
Net Income Common Stockholders$ -106.96M$ -151.97M$ -147.50M$ -112.19M$ -98.74M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 998.63M$ 1.06B$ 1.06B$ 634.13M$ 232.35M
Total Assets$ 1.07B$ 1.10B$ 1.08B$ 640.55M$ 237.96M
Total Debt$ 119.14M$ 118.06M$ 117.72M$ 117.19M$ 116.56M
Net Debt$ -879.49M$ -939.73M$ -941.34M$ -516.94M$ -115.79M
Total Liabilities$ 296.11M$ 242.67M$ 231.52M$ 235.21M$ 215.72M
Stockholders Equity$ 777.15M$ 857.12M$ 850.76M$ 405.33M$ 22.25M
Cash Flow-
Free Cash Flow$ -67.76M$ -140.08M$ -149.51M-$ -85.26M
Operating Cash Flow$ -66.98M$ -134.94M$ -149.16M$ -79.93M$ -84.92M
Investing Cash Flow$ -202.39M$ -122.10M$ 98.05M$ -362.12M$ 50.20M
Financing Cash Flow$ 7.46M$ 134.12M$ 573.71M$ 479.92M$ 19.58M
Currency in USD

Madrigal Pharmaceuticals Earnings and Revenue History

Madrigal Pharmaceuticals Debt to Assets

Madrigal Pharmaceuticals Cash Flow

Madrigal Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis